OpenVSafe by OpenVAERS
Search V-safe

EUL-39866-25251

2 vaccinations 4 coded responses 24 check-ins 4 free-text entries 4 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
549 / WI
Registered
2020-12-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-17
    Registered in v-safe
  3. 2020-12-17
    Survey response — days 1–6 daily, dose 1
    MedDRA: Fatigue — Feeling: Fair · Site: Pain
    Free text: Fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Abdominal pain · Be unable to work
    Adult check-in
  5. 2020-12-18
  6. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  7. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-23
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2020-12-30
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-06
    Dose 2 — Pfizer-BioNTech
  13. 2021-01-06
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-01-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-01-07
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  16. 2021-01-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-01-08
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  18. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  19. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-01-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  23. 2021-01-20
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-01-27
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-02-03
    Survey response — day 28, dose 2
    MedDRA: Headache, Nasal congestion, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair
    Free text: Stuffy nose, runny nose, headache, sore throat. Tested negative for Covid
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-02-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-02-17
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-04-07
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-07-07
    Survey response — 6 months, dose 2
    MedDRA: Pregnancy — Feeling: Fair
    Free text: Pregnancy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  30. 2022-01-06
    Survey response — 12 months, dose 2
    MedDRA: COVID-19, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: RSV end of Oct 2021. COVID from about 11/15/21-11/26/21.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-01-06
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  32. 2022-01-07
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-06Pfizer-BioNTech

Call center

4 call center cases

1 successful · 3 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-17

Systemic reaction (other): Fatigue

Release 3 — day 28, dose 2

2021-02-03

Symptoms: Stuffy nose, runny nose, headache, sore throat. Tested negative for Covid

Release 9 — 6 months, dose 2

2021-07-07

Symptoms: Pregnancy

Release 10 — 12 months, dose 2

2022-01-06

Symptoms: RSV end of Oct 2021. COVID from about 11/15/21-11/26/21.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDHeadache ✓ ✓ ✓
SDNasal congestion ✓ ✓ ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPregnancy ✓ ✓ ✓
SDRespiratory syncytial virus infection · · ✓
SDRhinorrhoea ✓ ✓ ✓
SDSARS-CoV-2 test negative ✓ ✓ ✓
SROFatigue ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release